Category Archives: HIV Prevention

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]

Subsequent HPTN 052 data shows early HIV treatment is even more beneficial to patient, cost-effective

By on .

The good news keeps getting better for the HIV Prevention Trials Network (HPTN) 052 study, which found last year that HIV-infected persons on antiretroviral therapy (ART) were 96 percent less likely to transmit the virus to an uninfected partner through vaginal sex. At the International AIDS Conference (IAC) in Washington this week, two late-breaker sessions […]

PEPFAR recommends integrating international TB screening guidelines into prevention of mother to child HIV transmission work

By on .

Pointing to mounting evidence of the impact of tuberculosis on the health of pregnant women and their children, the President’s Emergency Plan For AIDS Relief is recommending improvements to efforts to detect the disease in settings offering health services to pregnant women, women with HIV, newborns, and children. “Recent studies have shown that HIV-infected pregnant […]

CDC looks at TB/HIV syndemic, Lancet looks at expectations for Jim Kim, studies look at lower HIV risks for gay fathers, importance of healthy vaginas, and more. . .

By on .

CDC’s Grand Rounds feature examines past, future of HIV/TB response: In a world where an estimated 160 people die of tuberculosis every hour, where 25 percent of HIV/AIDS-related deaths are caused by TB, and where 9 million people can be expected to develop the disease each year, while untreatable forms of infection have emerged, “much […]

Analysis looks at fiscal savings, human toll

By on .

Unless Congress finds ways to lower the federal deficit by $1.2 trillion in the next five months,  the law passed last year mandating across-the-board cuts to nearly all budget items will reduce current global health spending by about 10 percent of its current level, an analysis by the Foundation for AIDS Research (amfAR) estimates. The […]

WHO’s HIV/TB update latest move toward treatment as prevention

By on .

The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health […]

Global Fund countries respond to realities, make more of their money

By on .

Facing uncertain future funding, countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria have used what they know about their own epidemics to redirect money to programs where it will have its greatest impact, the latest edition of Aidspan’s Global Fund Observer reports. The Fund has encouraged the effort during renewal […]

Breaking News: House committee approves 2013 funding for PEPFAR, Global Fund, global TB

By on .

The House Appropriations Committee voted on its fiscal year (FY) 2013 State and Foreign Operations Appropriations bill Wednesday and released a report that clarifies its funding intentions for key global health programs.  The bill includes $5.542 billion for global AIDS funding through the State Department, and the report specifies $4.243 billion to support the U.S. […]

UN: World will fall short of ambitious 2015 HIV/AIDS goals

By on .

The United Nations (UN) General Assembly gave some bad news Monday – the 2015 global HIV/AIDS targets will not be met unless there is significant scale up in several areas. The targets were set by the 2011 Political Declaration on HIV and AIDS: Intensifying our Efforts to Eliminate HIV and AIDS. The declaration was adopted […]

Antiretroviral therapy as prevention: TB

By on .

Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn.  “DOTS [directly observed TB therapy, short course] just isn’t doing it.” He called the […]